Lim Hunjong, Cho Se Jin, Baek Jung Hwan
Department of Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Eur Radiol. 2025 Feb;35(2):612-623. doi: 10.1007/s00330-024-10881-7. Epub 2024 Jul 24.
Ultrasound-guided thermal ablation, including radiofrequency ablation (RFA) and microwave ablation (MWA), has become one of the main options for treating benign thyroid nodules (BTNs). To assess the efficacy of thermal ablation of BTNs, we performed a systematic review and meta-analysis of relevant studies.
A comprehensive search of MEDLINE, EMBASE, and COCHRANE databases was performed up to September 25, 2023, to identify studies directly comparing RFA and MWA for pathologically proven BTNs and reporting clinical outcomes and complications. Data extraction and quality assessment were independently performed by two radiologists according to PRISMA guidelines. The analysis yielded the serial volume reduction ratios (VRRs) of ablated nodules for up to 12 months, symptom and cosmetic scores, and complications.
This analysis included nine studies with 1305 BTNs treated by RFA and 1276 by MWA. VRRs at 1 month, 3 months, and 6 months were similar between RFA and MWA, but RFA showed a significantly higher VRR (83.3%) than MWA (76.9%) at 12 months (p = 0.02). Complication rates showed no significant difference between the two methods. Symptom and cosmetic scores significantly decreased after ablation, without a significant difference between the methods. Subgroup analysis indicated a significantly higher VRR at 12 months for RFA than for MWA for less experienced investigators (≤ 10 years), but no significant difference for more experienced investigators (> 10 years).
RFA and MWA are both effective and safe methods for treating BTNs. RFA showed a higher VRR at 12 months and seems more suitable for less experienced investigators.
RFA and MWA are both effective and safe treatments for BTNs, with RFA showing a higher VRR at 12 months. Both methods offer minimally invasive and reliable treatment for thyroid nodules.
The most effective thermal ablation technique for BTNs remains undetermined. RFA showed a higher VRR at 12 months than MWA. Both techniques are effective for treating thyroid nodules; RFA offers greater benefits, particularly for less experienced investigators.
超声引导下热消融,包括射频消融(RFA)和微波消融(MWA),已成为治疗良性甲状腺结节(BTN)的主要选择之一。为评估BTN热消融的疗效,我们对相关研究进行了系统评价和荟萃分析。
截至2023年9月25日,对MEDLINE、EMBASE和COCHRANE数据库进行全面检索,以确定直接比较RFA和MWA治疗经病理证实的BTN并报告临床结局和并发症的研究。两名放射科医生根据PRISMA指南独立进行数据提取和质量评估。分析得出消融结节长达12个月的系列体积缩小率(VRR)、症状和美容评分以及并发症。
该分析纳入了9项研究,其中1305个BTN接受了RFA治疗,1276个接受了MWA治疗。RFA和MWA在1个月、3个月和6个月时的VRR相似,但RFA在12个月时的VRR(83.3%)显著高于MWA(76.9%)(p = 0.02)。两种方法的并发症发生率无显著差异。消融后症状和美容评分显著降低,两种方法之间无显著差异。亚组分析表明,经验不足(≤10年)的研究者中,RFA在12个月时的VRR显著高于MWA,但经验丰富(>10年)的研究者中无显著差异。
RFA和MWA都是治疗BTN的有效且安全的方法。RFA在12个月时显示出更高的VRR,似乎更适合经验不足的研究者。
RFA和MWA都是治疗BTN的有效且安全的方法,RFA在12个月时显示出更高的VRR。两种方法都为甲状腺结节提供了微创且可靠的治疗。
治疗BTN最有效的热消融技术仍未确定。RFA在12个月时的VRR高于MWA。两种技术都对治疗甲状腺结节有效;RFA益处更大,尤其是对经验不足的研究者。